Simplex Trading, LLC Global Blood Therapeutics, Inc. Transaction History

Simplex Trading, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$32.4 - $68.18 $105,300 - $221,585	3,250 New	3,250 $221,000
Q2 2022 Aug 03, 2022	SELL	$22.3 - $37.39 $238,922 - $400,596	-10,714 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$25.68 - $35.59 $569,659 - $789,492	-22,183 Reduced 67.43%	10,714 $371,000
Q3 2021 Oct 28, 2021	BUY	$25.48 - $37.34 $56,056 - $82,148	2,200 Added 7.17%	32,897 $1.23 Million
Q2 2021 Aug 12, 2021	BUY	$32.46 - $43.42 $700,292 - $936,743	21,574 Added 236.48%	30,697 $1.08 Million
Q1 2021 Apr 26, 2021	SELL	$38.94 - $50.85 $1.91 Million - $2.5 Million	-49,137 Reduced 84.34%	9,123 $371,000
Q4 2020 Feb 02, 2021	BUY	$37.65 - $63.77 $2.19 Million - $3.72 Million	58,260 New	58,260 $2.52 Million
Q2 2020 Jul 13, 2020	SELL	$48.73 - $81.82 $106,962 - $179,594	-2,195 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$41.72 - $87.2 $91,575 - $191,404	2,195 New	2,195 $112,000
Q3 2019 Oct 15, 2019	SELL	$45.35 - $57.91 $792,128 - $1.01 Million	-17,467 Closed	0 $0
Q2 2019 Jul 26, 2019	BUY	$52.6 - $63.29 $529,261 - $636,823	10,062 Added 135.88%	17,467 $918,000
Q1 2019 Apr 18, 2019	SELL	$39.99 - $53.48 $223,904 - $299,434	-5,599 Reduced 43.06%	7,405 $0
Q4 2018 Jan 16, 2019	BUY	$31.54 - $46.67 $94,178 - $139,356	2,986 Added 29.81%	13,004 $533,000
Q3 2018 Oct 23, 2018	BUY	$38.0 - $51.1 $380,684 - $511,919	10,018 New	10,018 $380,000
Q2 2018 Jul 30, 2018	SELL	$38.7 - $50.15 $527,674 - $683,795	-13,635 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$39.6 - $65.9 $539,946 - $898,546	13,635 New	13,635 $658,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.